Home | About Jay Hochman -Pediatric Gastroenterology Blog | Archives
January 25, 2018 7:01 am
A recent study (J Jalanka et al. AP&T 2018; 47: 371-9-thanks to Ben Gold for this reference) provide long-term data of fecal microbiota transplantation (FMT).
In this study of 84 adult patients who were treated for C difficile infection, 45 who had received FMT and 39 treated with antibiotics, the authors determined the frequency of adverse sequelae at 3.8 years using a retrospective questionnaire.
Key findings:
The authors note that FMT is frequently recommended based on three recurrences of C difficile infection and that their study would support using FMT earlier as a treatment option.
My take: Though a small study, these data suggest that FMT is effective and without long-term consequences.
Posted by gutsandgrowth
Categories: Gastroenterology
Tags: CHIP program, Clostridium difficile, Fecal Microbiota Transplantation
Mobile Site | Full Site
Get a free blog at WordPress.com Theme: WordPress Mobile Edition by Alex King.